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HLA Matching Assessed From Early Graft Function 
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Now THAT THE RESULTS of kidney 
transplantation are improving to rela-
tively high rates, we need more sensitive mea-
sures of transplant outcome than graft and 
patient survival. A subjective assessment by 
the transplant surgeon, evaluated as grade A, 
B, C. D, or Fat 3 months, 6 months, I year, 
and annually thereafter has long been avail-
able to the UCLA Transplant Registry but 
has been largely unused, primarily on the 
basis of credibility. We are particularly inter-
ested now in exploiting the extensive informa-
tion that is routinely recorded in the course of 
postoperative management of patients. It is 
not clear at present what forms of analysis will 
be informative. We report here the use of a 
summary score based on serum creatinine 
recorded during the early postoperative peri-
od-the first 60 days. 
METHODS 
Data on the posttransplant course of 438 transplants 
performed in 1982 and later at the University of Southern 
California, University of California at San Francisco, 
University of Texas at Houston, and the University of 
Pittsburgh were entered into computer storage. All 
patients were treated with cyclosporine A (CsA). Several 
different protocols were followed. Serum creatinine levels 
were expressed on a modified reciprocal scale (y - 100/ x 
if x> I, Y - 20(6 - x S)/5 if x < 1), and the i:laily aver-
age serum creatinine score (sts60) was computed, inter-
polating at days not tested, for each patient. Graft failure 
was equated with indefinitely large creatinine values. 
Records were merged with other registry information 
regarding HLA matching, donor/recipient sex, and other 
items. The data were analyzed by cross-tabulations, Stu-
dent's t tests, and regression analyses. Public HLA-A,B 
antigens were taken as defined by Konoeda and col-
leagues.' 
RESULTS 
The overall average SCS60 was 50 ± 25 
(SD), corresponding to serum creatinine of 
2.0 mg/l 00 mL. The averages by donor cate-
gory were 43 (cadaver donor regrafts, 
n = 53), 46 (cadaver donor first grafts, 
n = 307), 66 (no common haplotype living-
related donor, n = 9), and 71 (1 common 
haplotype living-related donor, n = 69). Re-
sults were consistent among the four centers. 
The difference between the one common 
haplotype living-related donor and first 
cadaver donor was strongly significant 
(t = 7.2, P < .0001). If one were to compare 
the two groups on a basis of I-year survival 
(assuming 90% and 75% survival, respec-
tively), approximately seven times the number 
of transplants (2,800) would be required to 
achieve the same level of statistical signifi-
cance. 
A preliminary finding of potential interest 
was a correlation among female recipients 
between the number of mismatches of both 
public and private A,B antigens with the 
creatinine score (P - .02). The number of 
mismatched antigens varied from 0 to 37. The 
regression equation was 63.0 - 0.S7x. The 
regressions on numbers of A,B- and B,DR-
mismatched private antigens were not statisti-
cally significant. In first cadaver transplants, 
female recipients tended to have better aver-
age graft function (50 v 42, P = .003) than 
did males, whereas transplants from male 
donors had better function (49 v 43, P = .02); 
the two effects were additive. 
Function assessed by the transplant sur-
geon's rating at 3 months after operation was 
correlated with mismatches for B,DR (P = 
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.0002, n = 2625 and P = .02, n = 3795 for 
transplants with and without CsA, respec-
tively). For CsA transplants, the results were 
89% ± 3% grade A or B for no B;DR mis-
matches and 74% ± 2% for 4 B,DR mis-
matches; corresponding values were 73% ± 
3% and 63% ± 2% for non-CsA. These find-
ings were based on transplants from many 
centers. 
DISCUSSION 
Although serum creatinine is not an ideal 
measure of kidney function,2 it is both com-
monly used and accessible. The strongest indi-
cation for sensitivity of increased outcome 
assessment was based on the comparison of 
parent and cadaver donor transplants (which 
could be reliably detected with -60 trans-
piants-IO parent, 50 cadaver). It may be 
that the SCS60 is largely detecting an uninter-
esting difference in early function, although 
there is no doubt that transplants with good 
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function through the early postoperative 
period have longer average survival rates than 
those with poor function. 
We chose to use reciprocal creatinine con-
centration since it correlates with clearance,) 
has better statistical properties, and has the 
natural extension of zero corresponding to a 
failed graft. 
There are many other possible ways of 
using serum creatinine. Among those that 
should be interesting are scores a veraged over 
windows other than the first 60 days and 
life-table analysis using accumulated SCS as 
the measure of survival. 
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